Apollon Wealth Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1764387
MOUNT PLEASANT, SC
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$432,810
+$225,702 QoQ
Shares Held
2,568
+48.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#501
of 773 holders
Holding Since
Dec 2022
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $15,358,516 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
22,585 | $12,237,230 | |
| 2 | ZTS |
Zoetis Inc.
|
14,109 | $1,013,872 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,568 | $432,810 | |
| 4 | VTRS |
Viatris Inc
|
22,397 | $355,664 | |
| 5 | LQDA |
Liquidia Corp
|
4,075 | $324,899 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,779 | $308,302 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,834 | $265,415 | |
| 8 | HLN |
Haleon plc
|
20,563 | $191,852 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,810 | 2,568 | Shares | Sole | 2026-07-23 | |
| 2022-12-31 | $207,108 | 1,734 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||